Jennifer Whitmore
Nurse Practitioner · Waterloo, NYNPI 1205405743
Payments from drug & device makers
Across 429 payments — averaging $18.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$1K
- AstraZeneca$1K
- Novo Nordisk$917
- AbbVie$759
- GSK$536
- Boehringer Ingelheim$516
- plus $3K from 29 others
What the payments were for
- Food & beverage$7,872100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 73 | $1,062 |
| AstraZeneca | 49 | $1,003 |
| Novo Nordisk | 51 | $917 |
| AbbVie | 35 | $759 |
| GSK | 30 | $536 |
| Boehringer Ingelheim | 25 | $516 |
| Bayer | 23 | $449 |
| Exact Sciences | 20 | $362 |
| Lilly USA, LLC | 22 | $304 |
| Merck | 14 | $235 |
| Amgen | 13 | $215 |
| Idorsia Pharmaceuticals US Inc | 5 | $181 |
| Biohaven Pharmaceutical Holding Company Ltd. | 7 | $155 |
| Phathom Pharmaceuticals, Inc. | 6 | $142 |
| Otsuka America Pharmaceutical, Inc. | 6 | $141 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $136 |
| Xeris Pharmaceuticals, Inc. | 6 | $115 |
| Astellas Pharma US Inc | 4 | $109 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $106 |
| Johnson & Johnson | 5 | $78 |
| Inogen, Inc. | 6 | $66 |
| Paratek Pharmaceuticals, Inc. | 2 | $31 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $29 |
| Mannkind Corporation | 1 | $24 |
| Amarin Pharma, Inc. | 1 | $24 |
| Esperion Therapeutics, Inc. | 1 | $23 |
| Kowa Pharmaceuticals America, Inc. | 1 | $22 |
| Inspire Medical Systems, Inc. | 1 | $20 |
| Biohaven Pharmaceuticals, Inc. | 1 | $17 |
| Indivior Inc. | 1 | $17 |
| Corcept Therapeutics | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| Almatica Pharma LLC | 1 | $15 |
| Lundbeck LLC | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QUVIVIQ$113
How this compares
$7,872 in reported general payments places this provider in the 95th percentile of 4,112 nurse practitioner providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 37 | $58,997 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 55 | $36,741 |
| RybelsusSemaglutide | 17 | $28,840 |
| JardianceEmpagliflozin | 16 | $22,463 |
| Breo ElliptaFluticasone/Vilanterol | 22 | $9,964 |
| Xigduo XrDapaglifloz Propaned/Metformin | 14 | $7,636 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 11 | $6,864 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 119 | $3,026 |
| Aripiprazole | 13 | $2,529 |
| Celecoxib | 26 | $1,656 |
| Atorvastatin Calcium | 135 | $1,504 |
| Gabapentin | 93 | $1,457 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 33 | $1,254 |
| Rosuvastatin Calcium | 94 | $1,223 |
| Omeprazole | 91 | $1,014 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $917 | $87,83754 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $536 | $46,70577 claims |
| Boehringer IngelheimJardiance | $516 | $22,46316 claims |
| AstraZenecaBreztri Aerosphere | $1,003 | $6,86411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,112 nurse practitioner providers in New York.
Other nurse practitioner in Waterloo
- Patricia McGoldrickNew York$202K
- Michelle DartSyracuse$95K
- Susan KreppelWilliamsville$67K
- Kerry AhernEast Syracuse$55K
- Valerie StanleyAlbany$55K
- Jodi LogerfoNew York$48K
- Grace WlasowiczRochester$41K
- Melissa LevinElmhurst$34K
- Carla JungquistCanandaigua$28K
- Kelly WilmarthJohnson City$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.